SÜRMELİ, Z. G. Et Al. 2012. Zoledronic acid in combination with serine threonine phosphatase inhibitors induces cytotoxicity and apoptosis in human breast cancer cells via decreasing the activities of PP1 and PP2A. IMPAKT Breast Cancer Conference 2012 .

SÜRMELİ, Z. G., gürsoy, p., çakar, b., kısım, a., ATMACA, H., sezgin, c., ... KARABULUT, B.(2012). Zoledronic acid in combination with serine threonine phosphatase inhibitors induces cytotoxicity and apoptosis in human breast cancer cells via decreasing the activities of PP1 and PP2A . IMPAKT Breast Cancer Conference 2012

SÜRMELİ, ZEKİ Et Al. "Zoledronic acid in combination with serine threonine phosphatase inhibitors induces cytotoxicity and apoptosis in human breast cancer cells via decreasing the activities of PP1 and PP2A," IMPAKT Breast Cancer Conference 2012, 2012

SÜRMELİ, ZEKİ G. Et Al. "Zoledronic acid in combination with serine threonine phosphatase inhibitors induces cytotoxicity and apoptosis in human breast cancer cells via decreasing the activities of PP1 and PP2A." IMPAKT Breast Cancer Conference 2012 , 2012

SÜRMELİ, Z. G. Et Al. (2012) . "Zoledronic acid in combination with serine threonine phosphatase inhibitors induces cytotoxicity and apoptosis in human breast cancer cells via decreasing the activities of PP1 and PP2A." IMPAKT Breast Cancer Conference 2012 .

@conferencepaper{conferencepaper, author={ZEKİ GÖKHAN SÜRMELİ Et Al. }, title={Zoledronic acid in combination with serine threonine phosphatase inhibitors induces cytotoxicity and apoptosis in human breast cancer cells via decreasing the activities of PP1 and PP2A}, congress name={IMPAKT Breast Cancer Conference 2012}, city={}, country={}, year={2012}}